Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and BioLife Solutions (BLFS)
Analysts Are Upgrading BioLife Solutions, Inc. (NASDAQ:BLFS) After Its Latest Results
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2024 Earnings Call Transcript
Lake Street Reaffirms Their Buy Rating on BioLife Solutions (BLFS)
Analysts Conflicted on These Healthcare Names: BioNTech SE (BNTX), Xenon (XENE) and BioLife Solutions (BLFS)
BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates
BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates
BioLife Solutions GAAP EPS of -$0.22, revenue of $31.7M
BioLife Solutions Reports First Quarter 2024 Financial Results
ICU Medical (ICUI) Q1 Earnings and Revenues Surpass Estimates
BioLife Solutions, Inc. (BLFS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
BioLife Solutions, Inc. (BLFS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
$776 million fund manager finds bargains in small-cap stocks
$776 million fund manager finds bargains in small-cap stocks
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Intra-Cellular Therapies (ITCI)
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Intra-Cellular Therapies (ITCI)
Boston Scientific (BSX) Q1 Earnings and Revenues Top Estimates
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.